Nektar Therapeutics NKTR Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nektar Therapeutics's common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nektar Therapeutics's common stock, shares issued (in shares)?
- Nektar Therapeutics (NKTR) reported common stock, shares issued (in shares) of $29.47M in Q1 2026.
- How has Nektar Therapeutics's common stock, shares issued (in shares) changed year-over-year?
- Nektar Therapeutics's common stock, shares issued (in shares) decreased by 84.8% year-over-year, from $194.39M to $29.47M.
- What is the long-term trend for Nektar Therapeutics's common stock, shares issued (in shares)?
- Over 3 years (2022 to 2025), Nektar Therapeutics's common stock, shares issued (in shares) has grown at a -46.1% compound annual growth rate (CAGR), from $188.56M to $29.47M.